Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: Correlation with stage and performance status

International Journal of Cancer

Volumn 98, Issue 1, 2002, Pages 84-91

  Mantovani, Giovanni ^a   Macciò, Antonio ^b   Madeddu, Clelia ^a   Mura, Loredana ^a   Gramignano, Giulia ^a   Lusso, Maria Rita ^a   Mulas, Carlo ^a   Mudu, Maria Caterina ^a   Murgia, Viviana ^a   Camboni, Paolo ^a   Massa, Elena ^a   Ferreli, Luca ^a   Contu, Paolo ^a   Rinaldi, Augusto ^a   Sanjust, Enrico ^a   Atzei, Davide ^a   Elsener, Bernhard ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Carbonia Hospital   (Italy)

Author keywords

Cancer patients; Leptin; Oxidative stress (antioxidant enzymes); Proinflammatory cytokines; Stage ECOG PS

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; CISPLATIN; CYTOKINE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 2; INTERLEUKIN 6; LEPTIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLIC POTENTIOMETRY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HEALTH STATUS; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CISPLATIN; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; INTERLEUKIN-2; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 0036498014     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10143     Document Type: Article

References (53)

1. Oxidative stress: The paradox of aerobic life
2. Antioxidants and human disease: A general introduction
3. Protection against oxidants in biological systems: The superoxide theory of oxygen toxicity
4. Oxidative stress and glycemic regulation
5. Cytokine activity in cancer-related anorexia/cachexia: Role of megestrol acetate and medroxyprogesterone acetate
6. Free radicals and antioxidants in chemotherapy-induced toxicity
7. Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects
8. Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small lung cancer patients
9. Oxidant and antioxidant activity changes in patients with oral cancer and treated with chemotherapy
10. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients
11. Megestrol acetate in neoplastic anorexia/cachexia: Clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy
12. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients
13. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer
14. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites
15. Serum values of proinflammatory cytokines inversely correlate with serum leptin levels in patients with advanced stage cancer at different sites
16. How to characterize a biological antioxidant
17. Role of protein-SH groups in redox homeostasis: The erythrocyte as a model system
18. Altered glutathione anti-oxidant metabolism during tumor progression in human renal-cell carcinoma
19. Antioxidant status and human health. Use of cyclic voltammetry for the evaluation of antioxidant capacity of plasma and of edible plants
20. Evaluation of plasma low molecular weight antioxidant capacity by cyclic voltammetry
21. The antioxidant properties of thioctic acid: Characterization by cyclic voltammetry
22. The antioxidant status of patients subjected to total body irradiation
23. Free radicals and antioxidant in the year 2000: A historical look to the future
24. Antioxidant inhibitors for cancer therapy
25. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress
26. Glutathione redox system in oxidative lung injury
27. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer
28. Redox regulation of transcriptional activators
29. Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells
30. Persistent oxidative stress in cancer
31. Changes in glutathione redox cycling and oxidative stress response in the malignant progression of NB2 lymphoma cells
32. Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo
33. Depletion of tumour glutathione in vivo by buthionine sulphoximine: Modulation by the rate of cellular proliferation and inhibition of cancer growth
34. Lipid peroxidation, free radical production and antioxidant status in breast cancer
35. Lipid peroxidation and antioxidant system in the blood of cancerous patients with metastasis
36. Manganese superoxide dismutase expression as predictive marker for disease-free survival in head and neck squamous cell carcinoma
37. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients
38. Plasma peroxyl radical trapping capacity in lung cancer patients: A case control study
39. Role of antioxidant enzymes in brain tumors
40. Lipid peroxidation in brain tumours
41. Antioxidant enzyme levels in cancer
42. Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer
43. Oxidative stress at onset and in early stages of type I diabetes in children and adolescents
44. Molecular mechanisms of toxicant-induced immunosuppression: Role of second messengers
45. Exogenous glutamine requirement is confined to late events of T cell activation
46. Glutathione in health and disease: Pharmacotherapeutic issues
47. Variability in glutathione-dependent detoxication in vivo and its relevance to detoxication of chemical mixtures
48. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine
49. Increase in free radical generation and lipid peroxidation following chemotherapy in patients with cancer
50. Plasma antioxidant status after high-dose chemotherapy: A randomized trial of parenteral nutrition in bone marrow transplantation patients